INCY vs BIIB: Which Stock is Better?
Side-by-side comparison of Incyte Corp and Biogen Inc in 2026
INCY
Incyte Corp
$101.27
BIIB
Biogen Inc
$191.82
Key Metrics Comparison
| Metric | INCY | BIIB | Winner |
|---|---|---|---|
| Market Cap | $20.15B | $28.15B | BIIB |
| P/E Ratio | 15.80 | 21.82 | INCY |
| EPS (TTM) | $6.41 | $8.79 | BIIB |
| Revenue Growth | 0.3% | -0.1% | INCY |
| Gross Margin | 52.9% | 78.9% | BIIB |
Analyze INCY
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INCY or BIIB a better investment?
Comparing INCY and BIIB: Incyte Corp has a market cap of $20.15B while Biogen Inc has $28.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INCY and BIIB?
INCY (Incyte Corp) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INCY or BIIB?
Based on P/E ratios, INCY trades at a lower multiple (15.8x vs 21.8x).
Which is growing faster: INCY or BIIB?
INCY has higher revenue growth at 0.3% vs -0.1% for BIIB.
Which company is more profitable: INCY or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 52.9% for INCY.
Which is the larger company: INCY or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $28.15B compared to $20.15B for INCY.
Should I buy INCY or BIIB in 2026?
Both INCY and BIIB have investment merit. INCY trades at $101.27 while BIIB trades at $191.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INCY and BIIB stock?
Key differences: Market Cap ($20.15B vs $28.15B), P/E Ratio (15.8x vs 21.8x), Revenue Growth (0.3% vs -0.1%), Gross Margin (52.9% vs 78.9%).